Enhanced Bactericidal Activity of Engineered Human Lysozyme
Author Information
Author(s): Gill Avinash, Scanlon Thomas C., Osipovitch Daniel C., Madden Dean R., Griswold Karl E.
Primary Institution: Dartmouth College
Hypothesis
Can charge engineering improve the antibacterial activity of human lysozyme in the presence of inhibitory molecules?
Conclusion
The engineered human lysozyme variant shows improved antibacterial activity against drug-resistant bacteria without losing stability.
Supporting Evidence
- The engineered lysozyme variant retains wild type or better lytic activity in the absence of inhibitory biopolymers.
- The double mutant's kinetics are faster than those of wild type hLYS in the presence of F-actin.
- The study demonstrates that charge engineering can enhance lysozyme activity in the presence of inhibitory molecules.
Takeaway
Scientists made a special version of a protein that helps fight germs, and it works better even when there are things trying to stop it.
Methodology
The study involved designing and screening combinatorial libraries of charge engineered human lysozyme variants for antibacterial activity.
Limitations
The study primarily focused on specific mutations and may not account for all possible variations in lysozyme function.
Statistical Information
P-Value
0.001
Statistical Significance
p=0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website